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Objective: In an attempt to understand better the potential role of the T cell in the
pathogenesis of pulmonary fibrosis (PF) due to sulfur mustard gas inhalation, this study was
designed to analyze bronchoalveolar lavage (BAL) lymphocyte subsets and to determine
the ratio of CD4 to CD8 lymphocytes in BAL fluid.
Setting: University hospital.
Patients: Twenty-one veterans with mustard gas-induced pulmonary fibrosis and 20
normal veterans as control group.
Intervention: Chest roentgenograms, pulmonary function tests (PFTs), tests for carbon
monoxide diffusing capacity of the lung (DLCO), high-resolution CT scans of the chest, BAL
via fiberoptic bronchoscopy, analyses of BAL fluids for cellular and Flow-cytometric analysis
of the phenotype of bronchoalveolar cells were performed in all cases. A transbronchial
lung biopsy was done in all patients following BAL.
Results: Neutrophilic alveolitis was the predominant feature. Neutrophils (Po0:0001) and
eosinophils (P ¼ 0:0006) were the predominant cell types in the BAL fluid of patients with
PF. CD8 lymphocytes expressed as percentage or absolute number were significantly higher
in patients with PF than in healthy controls (22.9677.48% vs. 14.1677.73%, respectively;
P ¼ 0:0006; and 2.2870.84 vs. 1.1070.55 103 cells/ml, respectively; Po0:0001). The
CD4/CD8 ratio was significantly lower in patients with PF than in healthy controls
(0.7370.25 vs. 1.5870.67; Po0:0001). Except for the percentage and the absolute
number of the BAL fluid neutrophils (r ¼ 0:70, P ¼ 0:001: r ¼ 0:62, P ¼ 0:005;
respectively), no correlation was found between DLCO% and the other BAL cells. A
significant negative correlation was observed between the percentage of DLCO and both
the percentage and the absolute number of CD8 lymphocytes in BAL fluid in patients with
PF (r ¼ 0:81, P ¼ 0:0003; r ¼ 0:61, P ¼ 0:006; respectively). A significant correlation
was also seen between the percentage of DLCO and the CD4/CD8 ratio (r ¼ 0:60,
P ¼ 0:006) in our patients.Elsevier Ltd. All rights reserved.
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Role of T lymphocytes in pathogenesis of pulmonary fibrosis 787Conclusion: CD8 Tcells in BAL fluid were significantly elevated in patients with pulmonary
fibrosis. Patients with higher grades of pulmonary fibrosis expressed as percentage of
DLCO, revealed higher percentages and the absolute number of CD8 T cells and a lower
CD4/CD8 ratio.
& 2006 Elsevier Ltd. All rights reserved.Introduction
The toxicity of the chemical warfare blistering agent sulfur
mustard (2,20-dichlorodiethyl sulfide; SM) has been investi-
gated for nearly a century.1,2 This toxic gas can damage to
the eyes and respiratory tract when present in high doses.3
Pulmonary fibrosis (PF) is a well-known late complication
of sulfur mustard gas exposure in human.4 Although the
respiratory tract lesions represent the major debility after
sulfur mustard exposure, only a few studies have investi-
gated the pathophysiology of sulfur mustard-induced re-
spiratory diseases, in particular the mechanisms involved in
inflammatory processes.
CD8 T cells infiltrate the lung in many clinical conditions,
particularly in interstitial lung disease.5 The role(s) that CD8
T cells might be playing in the pathogenesis of inflammatory
lung disease is unclear at present, as is the direct
contribution of CD8 T cell effector activities to lung injury.
According to this fact alterations in bronchoalveolar lavage
(BAL) CD4/CD8 T cell subset ratios have been demonstrated
in a variety of different respiratory disorders and the
measurement of these changes may be diagnostically help-
ful. Therefore, the CD4/CD8 ratio in BAL is an index that is
considered, at least in clinical respiratory medicine, as
indicative for different types of interstitial lung disease. An
elevated CD4/CD8 ratio in BAL is often seen in patients with
sarcoidosis and other granuloma-producing diseases, such as
asbestosis, Crohn’s disease berryliosis, and rheumatoid
arthritis.6–10 A reduced CD4/CD8 ratio has been observed
in various other immunologic interstitial lung diseases,
including drug-induced alveolitis, extrinsic allergic alveoli-
tis, bronchiolitis obliterans organizing pneumonia (BOOP),
and in patients infected with HIV.11–14 A normal CD4/CD8
BAL proportion has been described in patients with silicosis
and asymptomatic granite workers.15,16
It could, therefore, be anticipated that the lymphocytes
may also play a role in the response to inhaled mustard gas.
In an attempt to understand better the potential role of the
T cell in the pathogenesis of PF due to sulfur mustard gas
inhalation; this study was designed to analyze BAL lympho-
cyte subsets and to determine the ratio of CD4 to CD8
lymphocytes in BAL fluid in our victims with PF.
Methods
Patient population
Of all the veterans admitted to our university teaching
hospital in 1986 with a single large exposure to sulfur
mustard gas, 21 male patients were enrolled into this study
after meeting all of the following criteria for PF diagnosis:
(a) an interstitial pattern on a chest roentgenogram, (b) a
restrictive pattern in spirometric studies, (c) a decreasedsingle-breath carbon monoxide diffusing capacity of the lung
(DLCO), and (d) a confirmatory transbronchial lung specimen
biopsy specimen showing evidence of interstitial pneumoni-
tis with varying degrees of interstitial fibrosis without
evidence of granuloma formation.17 The patients’ exposure
to sulfur mustard gas had been confirmed by studies on their
urine and vesicular fluid in 1986.
None of the patients had any evidence of connective
tissue disorders, sarcoidosis, eosinophilic granuloma, pneu-
moconiosis, carcinomatosis, or lymphoma. Patients with
evidence of bacterial, mycobacterial and fungal infections
were also excluded. All these patients had persistent
intermittent cough from their exposures till now. Gradual
decline in pulmonary function tests (PFTs) occurred follow-
ing the initial gas exposure. The diagnosis of PF was made
within 2 years of the acute and massive sulfur mustard gas
inhalation in these victims. All were treated by intermittent
low dose prednisolon (2.5–7.5mg) for more than 6 years. All
of the cases were lifetime nonsmokers. They signed a
written informed consent form and underwent a thorough
history and physical examination. Prior to undergoing
bronchoscopy and PFTs, oral corticosteroid therapy was
withdrawn for at least 1 month. A chest roentgenogram, an
ECG, and a high-resolution CT (HRCT) of the chest were
obtained in each patient. The HRCT scans were done with
1- to 1.5-mm sections taken at 1-cm intervals through the
entire thorax and were reconstructed using a bone
algorithm. The study was approved by the Ethics Committee
of our university.
Control group
The control group consisted of 20 normal, healthy nonsmok-
ing veterans with a mean (7SD) age of 35.6074.51 years old
(range, 29–48 years old); the control subjects had partici-
pated in the Iran–Iraq War but had not been exposed to
mustard gas. All subjects voluntarily entered the study and
signed an informed consent form before their enrollment.
All subjects had a complete history and physical examina-
tion. No subjects had a history of exposure to organic or
inorganic dusts. In addition to obtaining a chest radiograph
and an ECG for each subject, PFTs were measured prior to
bronchoscopy as well. The examination of BAL cells and the
determination of T cells were carried out for all cases using
the same techniques as described for the patients group. No
transbronchial biopsies were performed in the control
group.
Measurement of pulmonary function and DLCO
Prior to bronchoscopy, PETs were performed in all patients.
These tests were measured through spirometric and lung
volumes assessment according to the standards advocated
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cian did all spirometric and lung volumes measurements by
the helium dilution method with a Master Screen apparatus
(Erich Jaeger GmbH, Wuerzburg, Germany), and DLCO by
the single breathholding helium dilution method.19 Each
patient was well trained to give his best effort. Results were
expressed as percentage predicted based on accepted
reference standards.20 The highest values were chosen and
reported.Bronchoscopy and bronchoalveolar lavage (BAL)
All of the patients underwent a bronchoscopic examination
in 2005. Before any lung biopsy specimens were taken, BAL
was performed using a flexible fiberoptic bronchoscope
(Olympus BF1T; Tokyo, Japan). Each patient was premedi-
cated with atropine (0.75mg IM) before the procedure. Mild
sedation was achieved with intravenously administered
midazolam, and supplementary oxygen was given through-
out the procedure. Patient oxygenation was monitored by
pulse oximetry. After applying 4% lignocaine spray to the
nose and throat of the patient, the flexible bronchoscope
was introduced. Local anesthesia of the larynx was achieved
with topical 4% lignocaine, whilst a 2% solution was used
below the vocal cords to suppress coughing. The broncho-
scope was wedged for lavage in the middle lobe segmental
bronchus, and four 60-ml aliquots of sterile physiologic
saline solution warmed to 37 1C were infused. The fluid was
immediately recovered by gentle suction after each instilla-
tion. The first aliquot reflecting a bronchial sample was
discarded, while the others were pooled for our study. The
BAL fluid was passed through monolayer surgical gauze to
eliminate mucus. One small aliquot of this fluid was utilized
to count the total cell number, and another aliquot was spun
in a cytometer at 400 revolutions/min for 10min. The cell
pellet was washed once in Hanks’ balanced salt solution
(without calcium and magnesium). A May–Gru¨nwald–Giemsa
stain smear was used to identify the differential profiles
after cytospin preparation. Total cell counts were deter-
mined with a hemocytometer. The differential cell count of
lymphocytes, neutrophils, macrophages, and eosinophils
was made under light microscopy  1000 by counting
approximately 300 cells in a random field. The result was
expressed as cells  103/ml. The unconcentrated super-
natant was frozen at 70 1C before the protein was
measured.Transbronchial lung biopsy
A transbronchial lung biopsy was performed in all patients
following BAL. Biopsy specimens were obtained from all
three lobes on the right side or from the upper and lower
lobes of the left lung. The lung biopsy specimens were
interpreted by a pathologist who did not know the patient’s
clinical data. Individual slides of the lung biopsy specimens
were stained with hematoxylin-eosin and Masson trichome.
The degree of fibrosis was estimated in comparison with a
normal lung specimen. The degree of fibrosis was estimated
to be mild (+1), moderate (+2), or severe (+3) when there
was a respective increase of o25%, 25–40%, or440% in the
amount of collagen seen in the biopsy specimens.Flow-cytometric analysis of the phenotype of
bronchoalveolar cells
To determine the T-lymphocyte phenotype, we employed
immunofluorescent staining and flow cytometry. In order to
identify the proportions of T lymphocytes, CD4, CD8 T cells,
B cells and natural killer (NK) cells subpopulations of BAL
fluid, cells were simultaneously stained with fluorescein
isothiocyanate or (FITC) and phycoerythrin-conjugated (PE)
monoclonal antibodies (CD3, -CD4, -CD8, -CD19, -CD56)
(Beckon Dickinson, Mountain View, CA) according to the
manufacturer’s protocol.
To determine the borderline between stained and
unstained cells, cells were also stained with mouse IgG1
and IgG2a-conjugated FITC or PE. A cell gate containing
lymphocytes was established on the basis of forward and
side light scatter. Lymphocytes which were gated for CD3
expression, then further subdivided by CD4 or CD8
expression and analysed by two color flow cytometry
on a FACScan. In other words, the relative ratio of CD4 or
CD8 in CD3-positive cells was assayed by a dual-color
analysis. Data were obtained and analyzed using Becton
Dickinson BD LYSYS II and Cytometric Bead Array (CBA)
software (San Jose, CA).Statistical analyses
Data are presented as mean7SD unless otherwise stated.
Comparisons were made using the Mann–Whitney nonpara-
metric test for continuous data and by w2 analysis for
discontinuous data. Correlations between different para-
meters were determined by Spearman’s rank correlation
coefficient. Po0:05 was considered significant.Results
Demographics
The characteristics of all study subjects are listed in Table 1.
No control subject had an obstructive or restrictive pattern
in his PFTs. The two groups were similar in age (P ¼ 0:24).Chest radiography and high-resolution computed
tomographic examinations
On chest radiography (CXR), prominent reticular interstitial
shadows, which are usually diffuse and patchy and most
extensive in the lower zones, were seen in all cases.
Bilateral abnormalities that may be asymmetrical are
evident in all cases. However, overt honeycombing was not
seen. CXR was normal in 2 cases. No nodules were seen.
The most common findings on HRCT were bilateral,
reticular opacities with interlobular septal thickening c/w
‘‘fibrosis’’ (21 cases), ground-glass attenuation (10 cases),
subpleural, bibasilar rim of increased attenuation (20 cases)
and traction bronchiectasis (4 cases). Overt honeycomb
changes were not seen.
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Table 1 Demographic and physiologic data of patients with pulmonary fibrosis (PF) due to mustard gas exposure and normal
control subjects.
Controls (n ¼ 20) PF (n ¼ 21) P value
Age (y) 35.6074.51 37.2874.61 0.24
FVC, % of predicted 98.2272.07 61.4173.66 o0.0001
FEV1, % of predicted 97.6274.61 82.6476.16 o0.0001
DLCO (%) 96.4578.07 55.8179.73 o0.0001
Values are mean7SD.
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The biopsy specimens of the mustard gas-exposed patients
indicated that 9 patients had mild (+1) PF and 12 patients
had moderate (+2) PF.
BAL fluid cellular constituents
The cellular contents of BAL fluids in both groups are shown
in Table 2. Patients with PF had a higher total cell count than
the normal group, but it was not significant (P ¼ 0:06).
Total and differential cell counts in patients with PF
showed, when compared to healthy controls, an increase
both of neutrophil percentage (13.2573.94 vs. 2.4971.32;
Po0:0001) and neutrophil absolute number (12.1973.68 vs.
2.1571.08 103 cells/ml; Po0:0001). Eosinophil percen-
tage, as well as total count, showed a significant increase
in PF patients when compared to healthy controls
(2.3371.68 vs. 0.6470.71%, respectively; P ¼ 0:0002; and
2.2371.70 vs. 0.5570.60 103 cells/ml, respectively;
P ¼ 0:0006). No significant changes in lymphocyte mean
percentage and the absolute number of alveolar lympho-
cytes were seen when compared to the control group
(10.9072.57 vs. 9.3874.12%, respectively; P ¼ 0:11; and
10.0472.33 vs. 8.2573.71 103 cells/ml, respectively;
P ¼ 0:06). The proportion of alveolar macrophages, how-
ever, was significantly lower (Po0:0001) in patients with PF
than in the control group.
Lymphocyte subsets in BALF
The summarized results of the lymphocyte phenotyping in
the BALF of both the control and patients with PF are shown
in Table 3. The profile of T-cell subtypes showed that when
data were expressed as percentage or as absolute number of
positive cells, CD8 lymphocytes were significantly higher in
patients with PF than in healthy controls (22.9677.48 vs.
14.1677.73%, respectively; P ¼ 0:0006; and 2.2870.84 vs.
1.1070.55 103 cells/ml, respectively; Po0:0001). The
proportion of CD4 cells in BAL fluid was significantly
diminished in patients with PF compared to the control
group (15.8075.61 vs. 24.9279.59; P ¼ 0:0006), while the
absolute number of CD4 cells showed no significant
difference between the two groups (1.5770.59 vs.
1.9070.85; P ¼ 0:15).
Consequently, the CD4/CD8 ratio was significantly lower
in patients with PF than in healthy controls (0.7370.25 vs.
1.5870.67; Po0:0001).When CD3, B and NK alveolar lymphocytes were evaluated
either as a percentage or as absolute number, no significant
differences were found between the patients with PF and
the control group (see Table 3).
Comparison of the DLCO percentage with BAL fluid
cellular constituents
Except for the percentage and the absolute number of the
BAL fluid neutrophils (r ¼ 0:70, P ¼ 0:001: r ¼ 0:62,
P ¼ 0:005; respectively), no correlation was found between
DLCO% and the other BAL cells.
Comparison of the DLCO percentage with BAL
lymphocyte subpopulations
A significant negative correlation was observed between the
percentage of DLCO and both the percentage and the
absolute number of CD8 lymphocytes in BAL fluid in patients
with PF (r ¼ 0:81, P ¼ 0:0003; r ¼ 0:61, P ¼ 0:006;
respectively) (Fig. 1). A significant correlation was also seen
between the percentage of DLCO and the CD4/CD8 ratio
(r ¼ 0:60, P ¼ 0:006) (Fig. 2) in our patients.
Comparison of the parameters of pulmonary
function with BAL lymphocyte subpopulations
BAL Lymphocyte subpopulations, whether expressed as a
percentage or in cells per milliliter, had no significant
correlations with the PFT physiologic parameters.
Discussion
Respiratory disorders are the major cause of disability and
mortality in mustard victims. There are several studies
relevant to long-term respiratory disorders after mustard
exposure in Iranian warfare victims.4,21 Its chronic pulmon-
ary sequelae include airway narrowing or stricture, asthma,
chronic bronchitis, bronchiectasis, and PF. Therefore,
exposure to this gas should be added to the list of the
various causes of interstitial lung diseases and PF.22
In interstitial lung diseases, initial injury to epithelial
cells is thought to be followed by alveolitis. The alveolitis is
sometimes self-limiting, but may become progressive. In the
latter case, lung fibrosis occurs. The mechanisms for these
pathological changes are not fully understood. However,
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Table 3 Lymphocyte subpopulations in bronchoalveolar lavage from patients with PF due to mustard gas exposure and
normal subjects.
Controls (n ¼ 20) PF (n ¼ 21) P value
CD3 cells (%) 44.90710.32 42.3077.08 0.17
CD3 cells (103 cells/ml) 3.6071.66 4.1970.98 0.35
CD4 cells (%) 24.9279.59 15.8075.61 0.0006
CD4 cells (103 cells/ml) 1.9070.85 1.5770.59 0.15
CD8 cells (%) 14.1677.73 22.9677.48 0.0006
CD8 cells (103 cells/ml) 1.1070.55 2.2870.84 o0.0001
CD4/CD8 (ratio) 1.5870.67 0.7370.25 o0.0001
B cells (%) 5.2676.91 4.1475.66 0.57
B cells (103 cells/ml) 0.5070.60 0.3870.49 0.49
NK cells (%) 2.9176.65 1.4673.74 0.39
NK cells (103 cells/ml) 0.2070.41 0.3870.49 0.63
Values are mean7SD.
Table 2 Comparison of bronchoalveolar lavage fuid cellular constituents of pulmonary fibrosis (PF) is due to sulfur mustard
gas inhalation vs. the control group.
Controls (n ¼ 20) PF (n ¼ 21) P value
Recovery of BAL fluid (ml) 161.10712.64 149.52715.48 0.01
Number of cells ( 103/ml) 87.4077.48 93.04712.24 0.06
Macrophages (%) 85.4573.10 69.4875.79 o0.0001
Macrophages ( 103/m) 76.4577.77 68.57711.28 0.05
Lymphocytes (%) 9.3874.12 10.9072.57 0.11
Lymphocytes ( 103/m) 8.2573.71 10.0472.33 0.06
Neutrophils (%) 2.4971.32 13.2573.94 o0.0001
Neutrophils ( 103/m) 2.1571.08 12.1973.68 o0.0001
Eosinophils (%) 0.6470.71 2.3371.68 0.0002
Eosinophils ( 103/m) 0.5570.60 2.2371.70 0.0006
Values are mean7SD.
Percentage of CD8 cells in the BAL fluid
5 10 15 20 25 30 35
D
lc
o 
(%
 of
 pr
ed
ict
ed
 va
lue
)
35
40
45
50
55
60
65
70
75
r=-0.81, p=0.0003
Figure 1 Relationship between the percentage of diffusion
capacity for carbon monoxide (DLCO) and the percentage of
CD8 T BAL cells in patients with pulmonary fibrosis (PF) due to
mustard gas inhalation. There is a significant, negative
correlation (P ¼ 0:0003, r ¼ 0:81) between the percentage of
DLCO and the percentage of CD8 T BAL cells in PF.
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Figure 2 Relationship between the percentage of diffusion
capacity for carbon monoxide (DLCO) and the CD4/ CD8 ratios in
patients with pulmonary fibrosis (PF) due to mustard gas
inhalation. A significant, positive correlation could be observed
(r ¼ 0:60, P ¼ 0:006).
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these diseases.15
The aim of this study was to characterize and compare
BAL lymphocyte subpopulations in patients presenting with
the clinical features of PF due to sulfur mustard gas
inhalation and healthy subjects. To the best of the authors’
knowledge, this is the first study in which BAL Lymphocyte
subpopulations have been evaluated in these victims.
We demonstrated that patients with PF, when compared
to healthy, were characterized by an increase eosinophils
and neutrophils in BAL fluid. A positive correlation between
either the percentage or the absolute number of BAL fluid
neutrophils and percentage of DLCO from patients with PF
has already been demonstrated.22 This study group corro-
borates our previous findings.22 These data also clearly
demonstrate that the degree of lung function impairment
closely related to neutrophilic alveolitis in patients with PF.
It might act as a triggering factor in the development of PF
in mustard gas-exposed patients.
The role of CD4+ or CD8+ T-cells in the regulation of PF
has been investigated in several models of fibrosis.5,6,12,15
Analysis of T-lymphocyte subsets in BAL fluid indicates that,
in patients with PF due to mustard gas exposure, CD4 T cells
decrease and both the percentage and total numbers of CD8
T cells increase. This study on BAL fluid has also shown that
the CD4/CD8 ratio is significantly decreased in patients with
PF. We measured the relationship between T-lymphocyte
subsets and physiologic indexes of pulmonary function tests
in the patients with PF due to mustard gas inhalation. The
percentage and the absolute number of CD8 T cells highly,
negatively correlated with the percentage of DLCO
(r ¼ 0:81, P ¼ 0:0003; r ¼ 0:61, P ¼ 0:006; respectively).
As reported in other studies, the single breath DLCO is a very
sensitive parameter for following-up deterioration and
response to therapy in patients with idiopathic PF.23,24
Therefore, we present a set of observations that reveal that
patients with more advanced lung function impairment as
reflected by the DLCO, tended to reveal lower CD4/CD8
ratios.
Furthermore, it should be mentioned that the role of CD8
T-cells would be important in sulfur mustard gas-induced PF,
since the CD8 population is greater than CD4 T-cell subset in
the BAL fluid. The CD8 T-cell population could also be
functionally divided into two subsets, Tc1 and Tc2, based on
the cytokine secretion pattern.25 Recent reports disclosed
that they may contribute to tumor rejection, protection
against viral infection, and pathological changes in chronic
obstructive pulmonary diseases.26,27
Therefore, It is possible that increased CD8 T cells in the
BAL fluid may contribute to parenchymal destruction and
therefore to the development of chronic fibrosis in these
patients by releasing cytokines capable of increasing the
susceptibility of target cells to cytotoxicity, or by secreting
chemokines that attract other cells to the site of inflamma-
tion.28,29 The significant correlation observed in our veter-
ans between increased number of CD8 Tcells in the BAL fluid
and reduced percentage of DLCO supports this hypothesis.
Although CD8 T cells are important effectors of cell-
mediated immunity, their precise role in the pathogenesis of
mustard gas-induced PF is unclear. An initial insult may lead
to an influx of acute and chronic inflammatory cells that
maintain immunological and inflammatory responses andthus produce progressive disease. It may be generally
accepted that immune mechanisms are likely to make a
contribution to pathogenesis; circumstantial support for an
immunopathogenetic hypothesis includes the abundance of
CD8 T-cells within the lung interstitium. Other inflammatory
cells may be involved. Macrophages may produce a number
of cytokines and neutrophils are likely to contribute to
tissue damage by the generation of oxygen radicals and
proteolytic enzymes.30 Eosinophils may contribute to lung
injury through release of secretory products (eosinophilic
cationic protein, vasoactive amines), cationic protein,
vasoactive amines.31 Therefore, the end result of inflam-
matory and immunological events in mustard gas-induced PF
is the presence of excess collagen within the lungs.
This analysis of BAL fluid from our patients with PF as a
late sequela of massive sulfur mustard gas inhalation is
similar to an experimental model of bleomycin-induced PF,
it was found that the helper-to-suppressor ratio of T-cell
lymphocytes shifted with time, having a value 41 at the
beginning of the disease and a valueo1 at the latest phases
of disease.32
Overall, the BAL profile in our patients with PF due to
sulfur mustard gas inhalation is characterized by several
features: cell differentials with an increase in neutrophils,
eosinophils and a decreased CD4/CD8 ratio. These features
suggest this BAL profile pattern may be similar to the BAL
fluid cellular constituents in usual interstitial pneumonia
(UIP) but the finding of a decreased CD4/CD8 ratio (the
absolute value) in the BAL fluid may be somewhat similar to
cryptogenic organizing pneumonia (COP) or BOOP.33,34
In conclusion, CD8 T cells in BAL fluid were significantly
elevated in patients with PF. Patients with higher grades of
pulmonary fibrosis expressed as percentage of DLCO,
revealed higher percentages and the absolute number of
CD8 T cells and a lower CD4/CD8 ratio.
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